Пошуковий запит: (<.>U=Р569.696$<.>) |
Загальна кількість знайдених документів : 575
Представлено документи з 1 до 20
|
| |
1. |
Король П. О. 99mTc-ПСМА - радіонуклідна візуалізація раку передміхурової залози: інноваційне діагностичне направлення в ядерній медицині : (огляд) // Radiation Diagnostics, Radiation Therapy. - 2020. - № 3.
|
2. |
Gerashchenko G. V. A role of expression level of reference and investigated genes in prostate tumors for qPCR analysis // Biopolymers and Cell. - 2018. - 34, № 2.
|
3. |
Kotrikadze N. Activity and content of antioxidant enzymes in prostate tumors. — 2008 // Эксперим. онкология.
|
4. |
Nedzvetsky V. S. Advanced glycation end products, galectin-3, matrix metalloproteinase-9 activity in men with heart failure and concomitant benign prostatic hyperplasia with androgen deficiency // Мед. перспективи. - 2021. - 26, № 4.
|
5. |
Lazarenko R. M. Alterations in swelling-activated <$E bold roman Cl sup -> current associated with neuroendocrine differentiation of prostate cancer cells // Укр. біохім. журн.. - 2005. - 77, № 2 [спец. вип.].
|
6. |
Mankovska O. Analysis of Aurora kinases genes expression points on their distinct roles in prostate cancer development // The Ukr. Biochem. J.. - 2019. - 91, № 6.
|
7. |
Reznikov A. G. Antitumor effect of endothelial monocyte-activating polypeptide-II on human prostate adenocarcinoma in mouse xenograft model. — 2007 // Эксперим. онкология.
|
8. |
Reznikov A. G. Assessment of gold nanoparticle effect on prostate cancer LNCaP cells // Эксперим. онкология. - 2015. - 37, № 2.
|
9. |
Fiandalo M. V. Caspase control: protagonists of cancer cell apoptosis : (a rev.) // Эксперим. онкология. - 2012. - 34, № 3.
|
10. |
Jimenez Romero M. E. Clinical case of a patient undergoing radium-223 treatment following treatment with abiraterone acetate and enzalutamide // Experimental Oncology. - 2018. - 40, № 2.
|
11. |
Schrader A. J. Clinical impact of MDR1-expression in testicular germ cell cancer. — 2007 // Эксперим. онкология.
|
12. |
Melnychuk M. P. Clinical significance of high grade and low grade prostate intraepithelial neoplasia // Мед. перспективи. - 2021. - 26, № 2.
|
13. |
Sakalо A. V. Clinical value detection of testicular microlithiasis and recently discovered markers in testicular germ-cell tumors // Здоровье мужчины. - 2018. - № 2.
|
14. |
Baltogiannis D. Combined use of antisense oligonucleotides and chemotherapeutics in the treatment of refractory prostate cancer. — 2005 // Эксперим. онкология.
|
15. |
Semenov D. V. Compensation of gene defect in <$E bold roman CASP3 sup {-~symbol Д~-}> human adenocarcinoma MCF-7 cells // Укр. біохім. журн.. - 2005. - 77, № 2 [спец. вип.].
|
16. |
Reznikov A. G. Cooperative antitumor effect of endothelial-monocyte activating polypeptide II and flutamide on human prostate cancer xenografts // Эксперим. онкология. - 2011. - 33, № 4.
|
17. |
Sak K. Current epidemiological knowledge about the role of flavonoids in prostate carcinogenesis : (a rev.) // Эксперим. онкология. - 2017. - 39, № 2.
|
18. |
Sak K. Current epidemiological knowledge about the role of flavonoids in prostate carcinogenesis : (a rev.) // Эксперим. онкология. - 2017. - 39, № 2.
|
19. |
Mevs L. V. Detection of prostate specific ETS fusion transcripts in cancer samples // Biopolymers and Cell. - 2017. - 33, № 4.
|
20. |
Gerashchenko G. V. Development of gene expression panels to determine prostate cancer // Доп. НАН України. - 2019. - № 1.
|
| |